The Effect of Hyperlipidemia on the Course of Diabetic Retinopathy-Literature Review

J Clin Med. 2022 May 13;11(10):2761. doi: 10.3390/jcm11102761.

Abstract

Diabetes mellitus is a very important social issue, and its retinal complications continue to be one of the major causes of blindness worldwide. The effect of glucose level on the development of retinal retinopathy has been the subject of numerous studies and is well understood. Hypertension and hyperlipidemia have been known to be important risk factors in the development of diabetes complications. However, the mechanisms of this effect have not been fully explained and raise a good deal of controversy. The latest research results suggest that some lipoproteins are closely correlated with the incidence of diabetic retinopathy and that by exerting an impact on their level the disease course can be modulated. Moreover, pharmacotherapy which reduces the level of lipids, particularly by means of statins and fibrate, has been shown to alleviate diabetic retinopathy. Therefore, we have decided to review the latest literature on diabetic retinopathy with respect to the impact of hyperlipidemia and possible preventive measures.

Keywords: diabetic retinopathy; hyperlipidemia; pharmacotherapy.

Publication types

  • Review

Grants and funding

This research received no external funding.